Human iPSC-Derived Spheroid Model with Oligodendrocytes and Microglia
Researchers created a human cell model using induced pluripotent stem cells (iPSCs), which includes mature oligodendrocytes and reactive microglia. This model simulates myelin damage and repair processes, demonstrating that new oligodendrocytes can help remyelinate axons, though with thinner myelin layers.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
This research provides insight into the cellular dynamics of myelin damage and repair, which is crucial for understanding multiple sclerosis and developing potential therapies.
What this does not prove
The study does not show the clinical efficacy of any therapies in humans, and findings from a cell model may not fully represent human conditions.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-01
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceA human-induced pluripotent stem cell-derived spheroid model to investigate myelin injury and repair. ↗DOI: 10.1038/s41593-026-02457-z
Supporting passages (3)
publication date2026-10-01
findingsHere we engineered a human iPSC-derived spheroid model enriched with mature, myelinating oligodendrocytes and functionally reactive microglia.
limitationsTitle: A human-induced pluripotent stem cell-derived spheroid model to investigate myelin injury and repair.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.